Section Arrow
VSTM.NASDAQ
- Verastem
Quotes are at least 15-min delayed:2026/01/09 07:15 EST
Pre Market
Last
 7.91
+0.04 (+0.51%)
Bid
7.83
Ask
8
High 8.13 
Low 7.26 
Volume 429 
Regular Hours (Closed)
Last
 7.87
+0.23 (+3.01%)
Day High 
8.13 
Prev. Close
7.64 
1-M High
10.5 
Volume 
3.06M 
Bid
7.83
Ask
8
Day Low
7.49 
Open
7.5 
1-M Low
6.68 
Market Cap 
575.44M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.55 
20-SMA 8.2 
50-SMA 8.84 
52-W High 11.245 
52-W Low 4.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.28/-1.41
Enterprise Value
616.70M
Balance Sheet
Book Value Per Share
-0.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.00M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1033-0.0223-17.75%-- 
Pre Market 0.1017 -0.0016 -1.55%
ACRVAcrivon Therapeutics1.93-1.02-34.58%-- 
Pre Market 1.83 -0.1 -5.18%
VTYXVentyx Biosciences13.84+0.11+0.80%-- 
Pre Market 13.81 -0.03 -0.22%
MLTXMoonLake Immunotherapeutics14.34+3.05+27.02%-- 
Pre Market 14.95 +0.61 +4.25%
CRMDCorMedix7.51-3.66-32.77%5.05PE
Pre Market 7.57 +0.06 +0.80%
Industry overview quotes are at least 15 minutes delayed
Business Description
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.